Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 18/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | BRD4 | O60885 | 2/20 | 1.00 |
| ▸ | BRD2 | P25440 | 2/20 | 1.00 |
| ▸ | BRD3 | Q15059 | 2/20 | 1.00 |
| ▸ | PIK3CD | O00329 | 1/20 | 1.00 |
| ▸ | PDE2A | O00408 | 1/20 | 1.00 |
| ▸ | PIK3C2A | O00443 | 1/20 | 1.00 |
| ▸ | PIK3R2 | O00459 | 1/20 | 1.00 |
| ▸ | PIK3C2B | O00750 | 1/20 | 1.00 |
| ▸ | PDE5A | O76074 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | PIM1 | P11309 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ly-294002 SCHEMBL29424167 | 1.00 | PRKDC (1.00) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| Ly-294002 SCHEMBL5078472 | 0.99 | ALDH1A1 (1.00) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL13496867 | 0.99 | PRKDC (0.97) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL31061056 | 0.95 | PRKDC (1.00) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL14041172 | 0.94 | PRKDC (1.00) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL5261685 | 0.90 | PRKDC (0.81) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL5260468 | 0.90 | PRKDC (0.81) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL4423159 | 0.90 | PRKDC (0.81) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL31060584 | 0.89 | PRKDC (1.00) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 | |
| SCHEMBL13700043 | 0.89 | PRKDC (0.80) | PRKDCALDH1A1KDM4ESMN1; SMN2BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2273 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122038285-A | Kit and method for constructing human bone organ by using pluripotent stem cells | 广东医科大学附属医院 | 2026-05-15 | — | — | CN | claimed |
| US-20260053761-A1 | USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER | UNIV OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2026-02-26 | — | — | US | claimed |
| US-20240252454-A1 | COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION | LEAD DISCOVERY CENTER GMBH (DE) | 2024-08-01 | — | — | US | claimed |
| EP-4333822-A1 | COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION | Lead Discovery Center GmbH (DE) | 2024-03-13 | — | — | EP | claimed |
| US-11898155-B2 | Method for introducing molecule and composition containing inhibitor | PEARL KOGYO CO., LTD. (JP) | 2024-02-13 | — | — | US | claimed |
| WO-2024026458-A2 | USE OF GLYCOGEN METABOLISM INHIBITORS FOR THE TREATMENT OF CANCER | THE UNIVERSITY OF VERMONT (US) | 2024-02-01 | — | — | WO | claimed |
| EP-3468559-B1 | METHODS OF USE AND PHARMACEUTICAL COMBINATIONS OF HDAC INHIBITORS WITH BET INHIBITORS | DANA FARBER CANCER INST INC (US) | 2023-11-22 | — | — | EP | claimed |
| US-20230323299-A1 | POPULATION OF TREG CELLS FUNCTIONALLY COMMITTED TO EXERT A REGULATORY ACTIVITY AND THEIR USE FOR ADOPTIVE THERAPY | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2023-10-12 | — | — | US | claimed |
| US-20230310452-A1 | BROMODOMAIN AND EXTRA TERMINAL DOMAIN (BET) INHIBITOR COMPOSITIONS AND METHODS THEREOF FOR USE AS ANTI-AGING AGENTS | MDI BIOLOGICAL LABORATORY (US) | 2023-10-05 | — | — | US | claimed |
| US-20230255974-A1 | USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER | UNIVERSITY OF VERMONT AND STATE AGRICULTURAL COLLEGE | 2023-08-17 | — | — | US | claimed |
| EP-1543119-A2 | METHODS OF INHIBITING HIV-1 VPR ACTIVITY AND HIV-1 INFECTIVITY USING ATR OR RAD17 INHIBITORS | UNIVERSITY OF ROCHESTER (US) | 2005-06-22 | — | — | EP | claimed |
| WO-2004090106-A2 | CRYSTAL STRUCTURES OF HUMAN PIM-1 KINASE PROTEIN COMPLEXES AND BINDING POCKETS THEREOF, AND USES THEREOF IN DRUG DESIGN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2004-10-21 | — | — | WO | claimed |
| EP-1442132-A2 | METHODS FOR THE TREATMENT OF OSTEOARTHRITIS AND COMPOSITIONS THEREOF | Novartis AG (CH) | 2004-08-04 | — | — | EP | claimed |
| EP-1196153-B1 | PROCESS FOR THE IMPROVEMENT OF SPERMATOZOA FERTILIZATION ACTIVITY | APPLIED RESEARCH SYSTEMS (AN) | 2003-11-19 | — | — | EP | claimed |
| WO-2003068929-A9 | METHODS OF INHIBITING HIV-1 VPR ACTIVITY AND HIV-1 INFECTIVITY USING ATR OR RAD17 INHIBITORS | UNIV ROCHESTER (US) | 2003-10-23 | — | — | WO | claimed |
| WO-2003068929-A2 | METHODS OF INHIBITING HIV-1 VPR ACTIVITY AND HIV-1 INFECTIVITY USING ATR OR RAD17 INHIBITORS | UNIVERSITY OF ROCHESTER (US) | 2003-08-21 | — | — | WO | claimed |
| WO-2003035048-A2 | METHODS FOR THE TREATMENT OF OSTEOARTHRITIS AND COMPOSITIONS THEREOF | NOVARTIS AG (CH) | 2003-05-01 | — | — | WO | claimed |
| JP-2003505412-A | — | — | 2003-02-12 | — | — | JP | claimed |
| EP-1196153-A2 | PROCESS FOR THE IMPROVEMENT OF SPERMATOZOA FERTILIZATION ACTIVITY | Applied Research Systems ARS Holding N.V. (AN) | 2002-04-17 | — | — | EP | claimed |
| WO-2001007021-A2 | PROCESS FOR THE IMPROVEMENT OF SPERMATOZOA FERTILIZATION ACTIVITY | APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) | 2001-02-01 | — | — | WO | claimed |